Repros Therapeutics Inc (NASDAQ:RPRX)

9.85
Delayed Data
As of Mar 05
 +0.14 / +1.44%
Today’s Change
5.92
Today|||52-Week Range
22.55
-1.20%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close9.71
Today’s open9.79
Day’s range-- - --
Volume334,123
Average volume (3 months)411,242
Market cap$236.0M
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-3.61%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...+0.18+1.73%
GALEGalena Biopharma Inc+0.05+2.56%
VTAEVitae Pharmaceutical...+0.07+0.63%
POZNPOZEN Inc+0.06+0.83%
Data as of 03/05/2015

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account